Holen Sie sich die Stockscreener-App
37.52
2.79%
1.02
Schlusskurs vom Vortag:
$36.50
Offen:
$36.73
24-Stunden-Volumen:
377.10K
Relative Volume:
1.02
Marktkapitalisierung:
$1.80B
Einnahmen:
$405.04M
Nettoeinkommen (Verlust:
$-17.90M
KGV:
-87.32
EPS:
-0.4297
Netto-Cashflow:
$7.66M
1W Leistung:
-6.43%
1M Leistung:
-13.53%
6M Leistung:
-12.44%
1J Leistung:
+25.61%
1-Tages-Spanne:
$36.57
$37.77
1-Wochen-Bereich:
$33.85
$40.93
52-Wochen-Spanne:
$21.97
$48.25
Artivion Inc Stock (AORT) Company Profile
Firmenname
Artivion Inc
Sektor
Branche
Telefon
(770) 419-3355
Adresse
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
37.52 | 1.75B | 405.04M | -17.90M | 7.66M | -0.4297 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-27 | Bestätigt | Lake Street | Buy |
| 2022-08-08 | Eingeleitet | Lake Street | Buy |
| 2022-03-03 | Eingeleitet | Stifel | Buy |
Alle ansehen
Artivion Inc Aktie (AORT) Neueste Nachrichten
Artivion Earnings Call Highlights Growth, Margin Momentum - TipRanks
Decoding Artivion Inc (AORT): A Strategic SWOT Insight - GuruFocus
Public Sector Pension Investment Board Has $6.86 Million Position in Artivion, Inc. $AORT - MarketBeat
Artivion, Inc. (AORT) Stock Analysis: Investors Eye 40.52% Potential Upside In Medical Device Innovator - DirectorsTalk Interviews
Artivion net income hits USD 2.4M in Q4 2025 - Medical Buyer
Ladenburg Thalmann & Co. Reaffirms Their Hold Rating on Artivion (AORT) - The Globe and Mail
Why Artivion (AORT) Is Down 7.6% After Mixed Q4 Results And 2026 Guidance Above Consensus - Yahoo Finance
Artivion (NYSE:AORT) Cut to "Hold" at Wall Street Zen - MarketBeat
Artivion (AORT) Stock Trades Down, Here Is Why - Finviz
AORT Q4 Deep Dive: Stent Graft and On-X Growth Offset By Tissue Flatness, Guidance Highlights Pipeline - Finviz
Artivion Q4 2025 slides: double-digit growth across product lines, strong 2026 outlook - Investing.com Nigeria
Artivion (AORT) Analyst Rating Update: Price Target Lowered by C - GuruFocus
Artivion (NYSE:AORT) Given New $48.00 Price Target at Canaccord Genuity Group - MarketBeat
Artivion (NYSE:AORT) Stock Price Down 6.5%Time to Sell? - MarketBeat
Canaccord Genuity lowers Artivion stock price target to $48 on market compression - Investing.com Australia
Canaccord Genuity lowers Artivion stock price target to $48 on market compression By Investing.com - Investing.com India
Artivion, Inc. (NYSE:AORT) Q4 2025 Earnings Call Transcript - Insider Monkey
Artivion, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Artivion Inc (AORT) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Artivion Q4 Earnings Call Highlights - MarketBeat
Artivion Q4 2025 slides: double-digit growth across product lines, strong 2026 outlook By Investing.com - Investing.com South Africa
Artivion Reports Strong 2025 Earnings, Outlook for Growth in 2026 - Intellectia AI
Artivion (AORT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Artivion earnings beat by $0.11, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Artivion Q4 2025 beats EPS forecast, stock rises - Investing.com
Artivion (NYSE:AORT) Misses Q4 CY2025 Sales Expectations - Finviz
Artivion (AORT) Q4 Earnings Surpass Estimates - Yahoo Finance
Artivion: Q4 Earnings Snapshot - KVUE
Artivion: Fourth Quarter Financial Highlights - Bitget
Artivion (NYSE:AORT) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Earnings Flash (AORT) Artivion, Inc. Reports Q4 Revenue $116.0M, vs. FactSet Est of $116.5M - marketscreener.com
Artivion shares fall as Q4 revenue misses analyst estimates - Investing.com Nigeria
Earnings Flash (AORT) Artivion, Inc. Posts Q4 Adjusted EPS $0.17 per Share, vs. FactSet Est of $0.06 - marketscreener.com
Artivion shares fall as Q4 revenue misses analyst estimates By Investing.com - Investing.com India
Artivion Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
MACD Signal: Will Artivion Inc stock go up in YEARWatch List & Low Drawdown Momentum Ideas - baoquankhu1.vn
Artivion earnings on deck: Can revenue growth offset profit concerns? - Investing.com South Africa
Artivion earnings on deck: Can revenue growth offset profit concerns? By Investing.com - Investing.com Nigeria
Artivion Becomes Oversold (AORT) - Nasdaq
Aug Wrap: Is Artivion Inc stock undervalued right nowSwing Trade & Real-Time Buy Zone Alerts - baoquankhu1.vn
What To Expect From Artivion's (AORT) Q4 Earnings - Finviz
Artivion Q4 2025 Earnings Preview: Revenue & EPS EstimatesNews and Statistics - IndexBox
What To Expect From Artivion’s (AORT) Q4 Earnings - TradingView
Is PDF Solutions Inc subject to activist investor interest2025 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Finanzdaten der Artivion Inc-Aktie (AORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):